美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

莱德尔

62.09

0.0000

成交量：- -

成交额：1,414.93万

市值：11.20亿

市盈率：-1,894.37

高：62.09

开：62.09

低：62.09

收：62.09

52周最高：62.12

52周最低：16.10

股本：1,803.72万

流通股本：1,699.84万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-0.0328

每股收益(LYR):-4.2422

净资产收益率：-0.22%

总资产收益率：3.14%

市净率：4.07

市盈率(LYR):-14.64

数据加载中...

总览公司新闻公告

诺华公司的 LEQVIO（英克西兰）在低密度脂蛋白胆固醇（LDL-C即 “坏胆固醇”）早期达标方面展现出具有统计学显著性

诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C

诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C

巨佬，点了根炸弹引线

新旧药物组合在人体试验中使胆固醇下降49%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/LDL/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LDL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDL\",,,,,undefined,":{"symbol":"LDL","market":"US","secType":"STK","nameCN":"莱德尔","latestPrice":62.09,"timestamp":1633032000000,"preClose":62.09,"halted":4,"volume":0,"delay":0,"floatShares":16998398,"shares":18037202,"eps":-0.032776,"marketStatus":"退市","change":0,"latestTime":"10-30 12:05:12 EDT","open":62.09,"high":62.09,"low":62.09,"amount":14149344.710749999,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.032776,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1761854400000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":62.09,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LDL\",,,,,undefined,":{"symbol":"LDL","floatShares":16998398,"roa":"3.14%","roe":"-0.22%","lyrEps":-4.242188,"shares":18037202,"dividePrice":0,"high":62.09,"amplitude":0,"preClose":62.09,"low":62.09,"week52Low":16.1,"pbRate":"4.07","week52High":62.12,"institutionHeld":0.9097,"latestPrice":62.09,"eps":-0.032776,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.032776,"open":62.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LDL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2021-10-01","symbol":"LDL","reason":null,"defaultRemindTime":1633095000000,"announcedDate":"2021-09-28","type":"delisting","dateTimestamp":1633060800000},{"market":"US","date":"2021-07-28","symbol":"LDL","fiscalQuarterEnding":"2021/06","expectedEps":0.41,"name":null,"time":"盘后","type":"earning","dateTimestamp":1627444800000,"reportTimeType":"post","actualEps":0.5},{"market":"US","date":"2021-04-27","symbol":"LDL","fiscalQuarterEnding":"2021/03","expectedEps":0.19,"name":null,"time":"盘后","type":"earning","dateTimestamp":1619496000000,"reportTimeType":"post","actualEps":0.35},{"market":"US","date":"2021-02-23","symbol":"LDL","fiscalQuarterEnding":"2020/12","expectedEps":0.07,"name":null,"time":"盘后","type":"earning","dateTimestamp":1614056400000,"reportTimeType":"post","actualEps":0.07},{"market":"US","date":"2020-10-27","symbol":"LDL","fiscalQuarterEnding":"2020/09","expectedEps":-0.11,"name":null,"time":"盘后","type":"earning","dateTimestamp":1603771200000,"reportTimeType":"post","actualEps":-0.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LDL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LDL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LDL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LDL","date":"2021-09-29","current":-1894.373932,"percent":0.006426,"low":-1953.243253,"twenty":-2.569621,"median":9.95639,"eighty":22.034281,"high":104.179034,"avg":-56.795719,"sd":348.820357,"marketCap":1117945779},"quantilePoints":[{"date":"2020-10-30","current":-2.42954,"twenty":7.81973,"median":18.299357,"eighty":23.110805,"marketCap":350944559},{"date":"2020-11-06","current":-2.350969,"twenty":7.735233,"median":18.196547,"eighty":23.06105,"marketCap":339595165},{"date":"2020-11-13","current":-2.821163,"twenty":7.673431,"median":18.168022,"eighty":22.98975,"marketCap":407514198},{"date":"2020-11-20","current":-3.066695,"twenty":7.571277,"median":18.097909,"eighty":22.933303,"marketCap":442981056},{"date":"2020-11-27","current":-3.444815,"twenty":7.421177,"median":18.014797,"eighty":22.893505,"marketCap":497600017},{"date":"2020-12-04","current":-3.667021,"twenty":7.346806,"median":17.950058,"eighty":22.848836,"marketCap":529697524},{"date":"2020-12-11","current":-3.689119,"twenty":7.281185,"median":17.903855,"eighty":22.809843,"marketCap":532889541},{"date":"2020-12-18","current":-3.885545,"twenty":7.19561,"median":17.835354,"eighty":22.763457,"marketCap":561263027},{"date":"2020-12-24","current":-3.660883,"twenty":7.161054,"median":17.779105,"eighty":22.736494,"marketCap":528810852},{"date":"2020-12-31","current":-3.7149,"twenty":7.142835,"median":17.654356,"eighty":22.648141,"marketCap":536613561},{"date":"2021-01-08","current":-4.09793,"twenty":7.138016,"median":17.642681,"eighty":22.627902,"marketCap":591941860},{"date":"2021-01-15","current":-4.123711,"twenty":7.093381,"median":17.585051,"eighty":22.567554,"marketCap":595665880},{"date":"2021-01-22","current":-4.034091,"twenty":7.060264,"median":17.548088,"eighty":22.509746,"marketCap":582720476},{"date":"2021-01-29","current":-3.759096,"twenty":6.978194,"median":17.469542,"eighty":22.464718,"marketCap":542997595},{"date":"2021-02-05","current":-3.973936,"twenty":6.958036,"median":17.442232,"eighty":22.459379,"marketCap":574031096},{"date":"2021-02-12","current":-4.09793,"twenty":6.907641,"median":17.377135,"eighty":22.459379,"marketCap":591941860},{"date":"2021-02-19","current":-3.951838,"twenty":6.868046,"median":17.298589,"eighty":22.435777,"marketCap":570839079},{"date":"2021-02-26","current":-8.100969,"twenty":6.691665,"median":17.238524,"eighty":22.405647,"marketCap":597243951},{"date":"2021-03-05","current":-8.946435,"twenty":-1.274748,"median":17.132064,"eighty":22.342913,"marketCap":659575930},{"date":"2021-03-12","current":-9.774142,"twenty":-1.463876,"median":17.05834,"eighty":22.273012,"marketCap":720598600},{"date":"2021-03-19","current":-8.962482,"twenty":-1.499449,"median":17.007728,"eighty":22.25825,"marketCap":660758996},{"date":"2021-03-26","current":-8.241279,"twenty":-1.567618,"median":16.852548,"eighty":22.222118,"marketCap":607588264},{"date":"2021-04-01","current":-8.248613,"twenty":-1.58113,"median":16.821512,"eighty":22.205307,"marketCap":608128983},{"date":"2021-04-09","current":-7.867231,"twenty":-1.635945,"median":16.552533,"eighty":22.160788,"marketCap":580011579},{"date":"2021-04-16","current":-7.784109,"twenty":-1.689041,"median":15.65042,"eighty":22.132957,"marketCap":573883427},{"date":"2021-04-23","current":-7.965021,"twenty":-1.730493,"median":14.562091,"eighty":22.095979,"marketCap":587221170},{"date":"2021-04-30","current":-54.470197,"twenty":-1.788356,"median":13.39391,"eighty":22.062043,"marketCap":665081105},{"date":"2021-05-07","current":-57.480742,"twenty":-1.828392,"median":12.819937,"eighty":22.057011,"marketCap":701839855},{"date":"2021-05-14","current":-54.263591,"twenty":-1.849146,"median":12.597753,"eighty":22.057011,"marketCap":662558446},{"date":"2021-05-21","current":-51.208774,"twenty":-1.909275,"median":12.371846,"eighty":22.057011,"marketCap":625259126},{"date":"2021-05-28","current":-54.411167,"twenty":-2.015562,"median":12.10128,"eighty":22.057011,"marketCap":664360345},{"date":"2021-06-04","current":-53.304349,"twenty":-2.091329,"median":11.996545,"eighty":22.057011,"marketCap":650846099},{"date":"2021-06-11","current":-52.979682,"twenty":-2.126479,"median":11.835078,"eighty":22.057011,"marketCap":646881920},{"date":"2021-06-18","current":-50.884107,"twenty":-2.192525,"median":11.542692,"eighty":22.057011,"marketCap":621294947},{"date":"2021-06-25","current":-127.95469,"twenty":-2.206817,"median":11.356204,"eighty":22.057307,"marketCap":1562326760},{"date":"2021-07-02","current":-89.304461,"twenty":-2.241141,"median":11.273483,"eighty":22.057307,"marketCap":1090407467},{"date":"2021-07-09","current":-89.52595,"twenty":-2.288538,"median":11.16597,"eighty":22.057307,"marketCap":1093111851},{"date":"2021-07-16","current":-89.776971,"twenty":-2.310087,"median":11.032127,"eighty":22.057307,"marketCap":1096176819},{"date":"2021-07-23","current":-90.342289,"twenty":-2.324221,"median":10.97508,"eighty":22.057307,"marketCap":1103079344},{"date":"2021-07-30","current":-1928.556675,"twenty":-2.350235,"median":10.879369,"eighty":22.064115,"marketCap":1105062975},{"date":"2021-08-06","current":-1931.703798,"twenty":-2.384531,"median":10.766637,"eighty":22.064115,"marketCap":1106866276},{"date":"2021-08-13","current":-1940.966623,"twenty":-2.401492,"median":10.611925,"eighty":22.064115,"marketCap":1112173875},{"date":"2021-08-20","current":-1942.225764,"twenty":-2.429806,"median":10.487285,"eighty":22.064115,"marketCap":1112895363},{"date":"2021-08-27","current":-1943.799691,"twenty":-2.446597,"median":10.39144,"eighty":22.068261,"marketCap":1113797223},{"date":"2021-09-03","current":-1951.984112,"twenty":-2.484784,"median":10.308062,"eighty":22.068261,"marketCap":1118486896},{"date":"2021-09-10","current":-1948.836257,"twenty":-2.50254,"median":10.189862,"eighty":22.068261,"marketCap":1116683175},{"date":"2021-09-17","current":-1950.095398,"twenty":-2.523075,"median":10.093855,"eighty":22.068261,"marketCap":1117404663},{"date":"2021-09-24","current":-1950.724969,"twenty":-2.558669,"median":10.008758,"eighty":22.057897,"marketCap":1117765407},{"date":"2021-09-29","current":-1951.039754,"twenty":-2.569621,"median":9.95639,"eighty":22.034281,"marketCap":1117945779}],"updateTime":1761840312079},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LDL\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2563889540","title":"诺华公司的 LEQVIO（英克西兰）在低密度脂蛋白胆固醇（LDL-C即 “坏胆固醇”）早期达标方面展现出具有统计学显著性","url":"https://stock-news.laohu8.com/highlight/detail?id=2563889540","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2563889540?lang=zh_cn&edition=fundamental","pubTime":"2025-08-30 23:02","pubTimestamp":1756566124,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0070302665.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","LU0320765489.SGD","BK4585","IE0009355771.USD","IE00BJT1NW94.SGD","BK4007","LDL","LU0208291251.USD","IE0002141913.USD","BK4532","IE00B2B36J28.USD","BK4588","IE00BFTCPJ56.SGD","NVS","BK4578"],"gpt_icon":0},{"id":"2556571588","title":"诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C","url":"https://stock-news.laohu8.com/highlight/detail?id=2556571588","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556571588?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 09:08","pubTimestamp":1754010482,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4578","IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","LU0208291251.USD","BK4007","IE0002141913.USD","IE00B2B36J28.USD","LDL","BK4588","IE0009355771.USD","IE00B4R5TH58.HKD","NVS","BK4585","LU0070302665.USD","BK4139","BK4505","IE00BFTCPJ56.SGD","RNA","LU0320765489.SGD","LU0211331839.USD","BK4532"],"gpt_icon":0},{"id":"2556130857","title":"诺华(NVS.US)siRNA疗法Leqvio再获FDA批准用于降低LDL-C","url":"https://stock-news.laohu8.com/highlight/detail?id=2556130857","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556130857?lang=zh_cn&edition=fundamental","pubTime":"2025-08-01 09:08","pubTimestamp":1754010482,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，江苏诺华公司今日宣布，美国FDA已批准其每年两次给药的小干扰RNA疗法Leqvio的扩展适应症申请，允许其作为单药，与饮食控制和运动联合使用，以降低成人高胆固醇血症患者的低密度脂蛋白胆固醇水平。Leqvio是一款“first-in-class”、靶向PCSK9 mRNA的siRNA疗法，最初于2021年12月获得美国FDA批准，作为饮食和他汀类药物治疗的辅助药物，用于治疗患有原发性高脂血症的成年患者，包括杂合子型家族性高胆固醇血症患者，以降低其LDL-C的水平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1324584.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","IE0009355771.USD","BK4585","BK4532","BK4007","IE00BJT1NW94.SGD","LDL","IE0002141913.USD","LU0211331839.USD","NVS","LU0208291251.USD","IE00B4R5TH58.HKD","BK4578","LU0070302665.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD"],"gpt_icon":0},{"id":"2542312314","title":"巨佬，点了根炸弹引线","url":"https://stock-news.laohu8.com/highlight/detail?id=2542312314","media":"瞪羚社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2542312314?lang=zh_cn&edition=fundamental","pubTime":"2025-06-10 20:05","pubTimestamp":1749557102,"startTime":"0","endTime":"0","summary":"2024年，其销售额达到了12.5亿美元，算是勉强达到了重磅炸弹的范畴。2024年evolocumab销售额突破了22亿美元，增幅达到了35.9%。这项试验计划纳入375名动脉粥样硬化性心血管疾病风险各异的成年参与者。在疗效相差不大的基础之上，大大增强了患者的依从性。CORALreef HeFH和CORALreef AddOn两项试验成功达到了其主要终点和所有关键次要终点。主要终点是第8周LDL-C相对于基线的平均变化百分比。默沙东扔下的这颗重磅炸弹，沉浸多年后终于爆炸了。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610201911a4a1f214&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250610201911a4a1f214&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","LU2468319806.SGD","LU2461242641.AUD","IE000M9KFDE8.USD","LU0058720904.USD","LU1989772923.USD","IE00BJT1NW94.SGD","SG9999014542.SGD","LU1974910355.USD","LU1989771016.USD","LU2112291526.USD","LU0266013472.USD","LU1934455277.USD","LU1162221912.USD","LU0320765646.SGD","LU0006306889.USD","LU0965509010.AUD","SG9999001176.USD","LU0203345920.USD","IE00BFTCPJ56.SGD","LU1585245621.USD","IE00BN8TJ469.HKD","IE0009355771.USD","LU1066051225.USD","LU1291159041.SGD","BK4559","LDL","IE00BLSP4239.USD","SG9999013999.USD","LU2106854487.HKD","LU1699723380.USD","IE00B2B36J28.USD","LU1917777945.USD","MRK","IE0002141913.USD","LU1934455194.USD","LU1941712264.USD","LU1430594728.SGD","LU0208291251.USD","LU0965509283.SGD","LU0211331839.USD","BK4550","LU0122379950.USD","LU1983299246.USD","LU1066051811.HKD","LU0238689110.USD","SG9999014575.USD","SG9999001176.SGD","LU0070302665.USD","BK4588"],"gpt_icon":0},{"id":"2536523381","title":"新旧药物组合在人体试验中使胆固醇下降49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536523381","media":"亿欧网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2536523381?lang=zh_cn&edition=fundamental","pubTime":"2025-05-19 10:36","pubTimestamp":1747622185,"startTime":"0","endTime":"0","summary":"克利夫兰诊所的一项新临床试验显示，对于高风险心脏病患者，降低低密度脂蛋白（LDL），即“坏”胆固醇的效果令人鼓舞。该研究结合了一种现有的胆固醇药物和一种尚未上市的新药，使低密度脂蛋白胆固醇水平降低了48.6%。这种组合疗法对那些尽管使用了他汀类药物和其他非他汀类药物，但仍未达到低密度脂蛋白胆固醇目标的患者尤为有效。研究涉及407名成年人，他们的低密度脂蛋白水平为70 mg/dL或更高，即使在使用降胆固醇治疗时也是如此。首席作者阿希什·萨拉朱博士强调，这种方法可以帮助高风险患者达到他们的胆固醇目标。\n\n\r\n            责任编辑：栎树","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://ky.jrj.com.cn/2025/05/19103650486708.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LDL"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}